Bio-Rad Laboratories, Inc.Class A vs Apple Inc.
BIO vs AAPL — side-by-side comparison from reported financials. BIO leads 2, AAPL leads 9 of 11 comparable metrics.
Bio-Rad Laboratories, Inc.Class A
BIO · Technology
$366.16+1.60%Strong
Apple Inc.
AAPL · Technology
$336.11-1.27%Strong
| Metric | BIO | AAPL |
|---|---|---|
| Price | $366.16 | $336.11 |
| Market cap | $9.79B | $4.91T |
| Revenue (TTM) | $2.59B | $467B |
| Revenue growth | -2.7% | +1.8% |
| Net margin | 8.6% | 27.6% |
| Free cash flow | $353M | $137B |
| Net cash (debt) | $339M | ($31.6B) |
| 1-year price return | +21.8% | +32.3% |
| P/E | 44.3 | 38.1 |
| P/E vs own history (cheap-side %) | 26% | 7% |
| Dividend yield | — | 0.32% |
| Return on equity | 3% | 137% |
| Altman Z-score | 3.41 | 12.84 |
| CV checks passed | 9 of 10 | 11 of 10 |
| Employees | 7,450 | 166,000 |
Full résumé-style profiles: BIO CV · AAPL CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.